Barcelona, Spain

Mónica Garcia Lopez

This inventor holds 1 USPTO granted patent. Top assignee: Laboratorios Del Dr. Esteve S.a.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mónica Garcia Lopez. Retrieved from https://idiyas.com/inventor/mónica-garcia-lopez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mónica Garcia Lopez: Innovator in Pharmacological Compounds

Introduction

Mónica Garcia Lopez is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target the 5-HT7 receptor. His work is crucial for advancing treatments for various central nervous system disorders.

Latest Patents

Mónica holds 1 patent related to his innovative research. The patent focuses on tetrahydroisoquinoline substituted sulfonamide compounds, which exhibit pharmacological activity towards the 5-HT7 receptor. This invention includes processes for preparing these compounds, pharmaceutical compositions that incorporate them, and their applications in treating diseases associated with serotonin involvement.

Career Highlights

Mónica is currently employed at Laboratorios del Dr. Esteve S.A., where he continues to push the boundaries of pharmaceutical research. His dedication to innovation in drug development has positioned him as a key figure in his field.

Collaborations

Mónica collaborates with Antoni Torrens Jover, enhancing the research and development efforts at their company. Their partnership exemplifies the importance of teamwork in scientific advancements.

Conclusion

Mónica Garcia Lopez is a pioneering inventor whose work in pharmacological compounds is making a significant impact on the treatment of CNS disorders. His contributions are vital for the future of medicine and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…